Zoom's Investment in Anthropic Yields Over $1 Billion Profit
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 57 minutes ago
0mins
Source: stocktwits
- Significant Investment Returns: Zoom's initial investment of approximately $51 million in Anthropic in May 2023 has surged to over $1.3 billion, demonstrating the company's strategic foresight and ability to generate substantial returns in the AI sector.
- Strong Financial Performance: Zoom reported Q1 revenue of $1.24 billion, a 5.5% year-over-year increase, with adjusted earnings rising to $1.55 per share, exceeding analyst expectations and prompting an upward revision of its full-year guidance, indicating robust market demand.
- Share Buyback Initiative: The company has authorized a $1 billion share buyback program aimed at enhancing shareholder value, reflecting confidence in future growth and further bolstering market sentiment towards its stock.
- Optimistic Analyst Ratings: According to Koyfin, 17 out of 30 analysts rate Zoom as a 'buy', indicating strong market confidence in its future performance, particularly in the context of its transition towards AI-driven business tools.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ZM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ZM
Wall Street analysts forecast ZM stock price to rise
20 Analyst Rating
12 Buy
7 Hold
1 Sell
Moderate Buy
Current: 96.750
Low
85.00
Averages
99.33
High
115.00
Current: 96.750
Low
85.00
Averages
99.33
High
115.00
About ZM
Zoom Communications, Inc. provides an artificial intelligence (AI) work platform for human connection. Zoom Workplace, the Company’s AI-powered, open collaboration platform built for modern work, enables us to streamline communications, increase employee engagement, optimize in-person time, improve productivity, and offer customer choice with third-party apps and integrations. Zoom Workplace, powered by Zoom AI Companion, includes collaboration solutions like meetings, team chat, phone, scheduler, whiteboard, spaces, Workvivo, and more. Its communication products include Zoom Meetings, Zoom Phone, Zoom Team Chat, Zoom scheduler, and Zoom mail and calendar. Its productivity products include Zoom Docs, Zoom Whiteboard, Zoom Clips, and Zoom Tasks. Its space products include Zoom Rooms, Zoom Workspace Reservation, and Zoom Visitor Management. It serves various industries, including education, financial services, government, retail, manufacturing and healthcare.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Revenue Growth: Zoom's total revenue for Q1 FY2027 increased by 5.5% year-over-year to $1.2 billion, with enterprise revenue rising 7.2% to $755.7 million, indicating robust market performance.
- Customer Expansion: The number of customers contributing over $100,000 grew by 8.2% to 4,534, demonstrating Zoom's success in servicing corporate clients and solidifying its market position.
- AI Product Promotion: The number of AI Companion paid users surged by 184%, while My Notes reached 1.5 million users within just four months, showcasing strong momentum in AI technology adoption and enhancing customer retention.
- Optimistic Profit Forecast: Management anticipates full-year revenue of approximately $5.1 billion, adjusted earnings per share between $5.96 and $6.00, and free cash flow of $1.7 billion, reflecting confidence in future growth.
See More
- Significant Investment Returns: Zoom's initial investment of approximately $51 million in Anthropic in May 2023 has surged to over $1.3 billion, demonstrating the company's strategic foresight and ability to generate substantial returns in the AI sector.
- Strong Financial Performance: Zoom reported Q1 revenue of $1.24 billion, a 5.5% year-over-year increase, with adjusted earnings rising to $1.55 per share, exceeding analyst expectations and prompting an upward revision of its full-year guidance, indicating robust market demand.
- Share Buyback Initiative: The company has authorized a $1 billion share buyback program aimed at enhancing shareholder value, reflecting confidence in future growth and further bolstering market sentiment towards its stock.
- Optimistic Analyst Ratings: According to Koyfin, 17 out of 30 analysts rate Zoom as a 'buy', indicating strong market confidence in its future performance, particularly in the context of its transition towards AI-driven business tools.
See More
- Revenue Growth: Zoom's total revenue for Q1 FY2027 rose 5.5% year-over-year to $1.2 billion, primarily driven by a 7.2% increase in enterprise revenue to $755.7 million, indicating strong performance in the corporate market.
- Customer Expansion: The number of customers contributing over $100,000 in trailing-12-month revenue grew by 8.2% to 4,534, demonstrating Zoom's success in maintaining and expanding its high-value customer base, which further strengthens its market position.
- AI Product Adoption: The number of AI Companion paid users surged by 184%, while My Notes reached 1.5 million licensed users within just four months of launch, reflecting strong demand for AI-driven tools and propelling the company's transformation into a comprehensive business communications platform.
- Optimistic Profit Forecast: Management expects full-year revenue of approximately $5.1 billion, adjusted earnings per share between $5.96 and $6.00, and free cash flow of $1.7 billion, reflecting confidence in future growth and commitment to shareholder returns.
See More
- Market Recovery: The S&P 500 rose by 0.37% and the Nasdaq 100 by 0.42%, with the Dow Jones Industrial Average hitting an all-time high, reflecting optimism about a potential US-Iran peace deal that could boost investor confidence.
- Consumer Sentiment Decline: The University of Michigan's consumer sentiment index was revised down to a record low of 44.8, below the expected 48.2, indicating growing concerns among consumers about the economic outlook, which may impact future spending.
- Rising Inflation Expectations: The 1-year inflation expectations for May were revised upward to 4.8%, exceeding the expected 4.6%, potentially prompting the Federal Reserve to consider interest rate hikes in upcoming meetings, which could pressure the stock market.
- Tech Stocks Lead Gains: Workday's stock surged over 5% after reporting Q1 adjusted EPS of $2.66, surpassing expectations, highlighting strong performance in the software sector and potentially attracting more investor interest in tech stocks.
See More
- Strong Market Performance: The S&P 500 rose by 0.50% and the Nasdaq 100 by 0.73%, with the Dow Jones Industrial Average hitting an all-time high, reflecting optimism about a potential US-Iran peace deal that could boost investor confidence.
- Decline in Consumer Confidence: The University of Michigan's consumer sentiment index was revised down to 44.8, a record low, below the expected 48.2, indicating growing consumer concerns about the economic outlook, which may negatively impact future spending.
- Rising Inflation Expectations: The 1-year inflation expectations for May were revised up to 4.8%, a 9-month high, exceeding the expected 4.6%, which could prompt the Fed to consider interest rate hikes at the upcoming meeting, affecting market liquidity.
- Chip Stocks Lead Gains: Qualcomm's stock surged over 12%, leading the Nasdaq 100, demonstrating ongoing market enthusiasm for semiconductor and AI infrastructure, which may yield higher returns for related companies.
See More
- Lenovo's Performance Boost: Lenovo reported an 84% increase in AI-related revenue for Q4, leading to a nearly 20% surge in its stock price, which also propelled Dell and HP shares up over 15%, reflecting strong market demand and competitive positioning in AI technology.
- Estee Lauder's Stock Recovery: Estee Lauder's shares rose 10% despite ending merger talks with Puig, indicating robust market performance and a solid position in the cosmetics industry.
- Workday's Strong Results: Workday's stock jumped nearly 4% after posting better-than-expected earnings and raising its full-year margin outlook, showcasing its growth potential in finance and HR software.
- Merck's Drug Breakthrough: Merck's lung cancer treatment, developed in partnership with Kelun-Biotech, demonstrated a 65% reduction in tumor progression risk in a phase 3 study, resulting in a nearly 5% increase in stock price, reinforcing its competitive edge in oncology.
See More











